SIM
PCRX icon

SSI Investment Management’s Pacira BioSciences PCRX Stock Holding History

SSI Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,433
Closed -$311K – 402
2014
Q1 		$311K Sell
4,433
-6,869
-61% -$467K 0.03% 319
2013
Q4 		$650K Buy
11,302
+50
+0.4% +$2.63K 0.06% 302
2013
Q3 		$540K Buy
+11,252
New +$410K 0.05% 295

Other funds holding PCRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return

SSI Investment Management's PCRX Position: Q2 2014 in Review

SSI Investment Management sold out of Pacira BioSciences (PCRX) in Q2 2014, closing a stake of 4,433 shares — an estimated $311K sold.

SSI Investment Management first reported a position in PCRX in Q3 2013 and held it in 3 quarters. The position peaked at $650K in Q4 2013. 191 funds tracked by Wall St. Rank hold PCRX as of Q2 2014.

  • SSI Investment Management reported no remaining Pacira BioSciences position as of Q2 2014 after selling out during the quarter.
  • SSI Investment Management sold 4,433 Pacira BioSciences shares in Q2 2014, an estimated $311K.
  • SSI Investment Management first reported a position in Pacira BioSciences in Q3 2013 and held it in 3 quarters.
  • SSI Investment Management's Pacira BioSciences position peaked at $650K in Q4 2013.
  • 191 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2014.

Based on SSI Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.